Sponsor:
Orion Corporation, Orion Pharma
Code:
NCT07563738
Conditions
Mesothelioma
Pancreatic Cancer
NSCLC (Advanced Non-small Cell Lung Cancer)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ODM-212
Ipilimumab and nivolumab
Gemcitabine and nab-paclitaxel
sotorasib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-07. This information was provided to ClinicalTrials.gov by Orion Corporation, Orion Pharma on 2026-05-04.